Free Trial

Symrise (ETR:SY1) Trading Up 0.5% - Still a Buy?

Symrise logo with Basic Materials background

Key Points

  • Symrise AG's stock increased by 0.5%, closing at €79.66 ($93.72), after trading approximately 226,870 shares.
  • The company has a market cap of $11.39 billion and a price-to-earnings ratio of 29.08, indicating its valuation metrics within the market.
  • Symrise operates in two segments: Taste, Nutrition & Health and Scent & Care, providing various ingredients and solutions across multiple industries.
  • Want stock alerts on Symrise? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Shares of Symrise AG (ETR:SY1 - Get Free Report) were up 0.5% during mid-day trading on Friday . The stock traded as high as €79.66 ($92.63) and last traded at €79.66 ($92.63). Approximately 226,870 shares changed hands during trading, The stock had previously closed at €79.26 ($92.16).

Symrise Trading Up 1.1%

The company has a market capitalization of $11.51 billion, a PE ratio of 29.40, a price-to-earnings-growth ratio of 2.00 and a beta of 0.49. The company's fifty day moving average is €89.62 and its 200-day moving average is €95.14. The company has a debt-to-equity ratio of 67.90, a current ratio of 2.97 and a quick ratio of 1.39.

Symrise Company Profile

(Get Free Report)

Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. It operates through two segments, Taste, Nutrition & Health; and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and product solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for fish feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.

Read More

Should You Invest $1,000 in Symrise Right Now?

Before you consider Symrise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Symrise wasn't on the list.

While Symrise currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines